Myanmar vs Papua New Guinea: Number of deaths from cardiovascular diseases by type
Myanmar
752.07 deaths
in 2021
Papua New Guinea
741.19 deaths
in 2021
Myanmar rank
30th
Papua New Guinea rank
31st
Number of deaths from cardiovascular diseases by type over time
- Myanmar
- Papua New Guinea
How they compare
Myanmar currently reports 752.07 deaths against 741.19 deaths in Papua New Guinea, a difference of 10.88 deaths.
Across all 22 years both countries report, Myanmar has been ahead every year.
Myanmar ranks 30th and Papua New Guinea ranks 31st of 194 countries.
Myanmar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Myanmar | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1,445 deaths | 581.4 deaths | 863.45 deaths | Myanmar |
| 2010s | 900.32 deaths | 726.46 deaths | 173.86 deaths | Myanmar |
| 2020s | 769.32 deaths | 716.67 deaths | 52.65 deaths | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of deaths from cardiovascular diseases by type, Myanmar or Papua New Guinea?
- Myanmar, at 752.07 deaths against 741.19 deaths in Papua New Guinea as of 2021.
- What is the difference in number of deaths from cardiovascular diseases by type between Myanmar and Papua New Guinea?
- 10.88 deaths, with Myanmar ahead.
- How many years of comparable data are there for Myanmar and Papua New Guinea?
- 22 years are reported by both, from 2000 to 2021.
- How do Myanmar and Papua New Guinea rank globally for number of deaths from cardiovascular diseases by type?
- Myanmar ranks 30th and Papua New Guinea ranks 31st of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Number of deaths from cardiovascular diseases by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from rheumatic heart disease in both sexes.